D-0618-2020 Class III Terminated
FDA drug recall D-0618-2020 was initiated by Glenmark Pharmaceuticals Inc., USA on Nov 15, 2019 and is designated Class III. Reason for recall: Defective delivery system; product is not foaming or is coming out as liquid. The recall status is terminated (terminated Mar 15, 2024). Affected quantity: a) 34521 bottles; b) 16930 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2019
- Initiation Date
- Nov 15, 2019
- Termination Date
- Mar 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 34521 bottles; b) 16930 bottles
Product description
Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No.: B-25, MIDC, Shendra Aurangabad - 431210, Maharashtra, India Manufactured for: Glenmark Pharmaceuticas Inc. USA Mahwah, NJ 07430
Reason for recall
Defective delivery system; product is not foaming or is coming out as liquid.
Distribution pattern
Nationwide
Code information
a) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021 b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0618-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026